Trials / Completed
CompletedNCT01359917
Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome
Psychological Morbidity and Facial Volume in HIV Lipodystrophy:
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- NHS Lothian · Other Government
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The hypotheses of this study were that: 1. HIV lipodystrophy is associated with psychological morbidity relating to body image, anxiety and depression. 2. Treatment of HIV lipodystrophy using autologous fat transfer, polylactic acid or Bio-alcamid, is associated with an improvement in psychological morbidity and anatomical volume of treated areas. 3. The DI3D system is a valid and reproducible method of recording and measuring facial 3-D volume.
Detailed description
as above
Conditions
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2011-05-25
- Last updated
- 2011-06-13
Source: ClinicalTrials.gov record NCT01359917. Inclusion in this directory is not an endorsement.